Cargando…
2320. Novel checkpoint modifier lowers T cell activation threshold and enhances and broadens vaccine-induced responses to chronic viral infections
BACKGROUND: Vaccines aim to induce immune responses that prevent disease. They may also clear chronic infections or reduce tumor progression. Vaccine adjuvants augment immune responses, in general, by providing stimulatory signals. Our focus has been on a different type of adjuvant that enhances vac...
Autores principales: | Hasanpourghadi, Mohadeseh, Luber, Andrew, Currie, Sue, Magowan, Colin, Zhou, Xiangyang, Ertl, Hildegund C J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752140/ http://dx.doi.org/10.1093/ofid/ofac492.151 |
Ejemplares similares
-
COVID-19 Vaccines Based on Adenovirus Vectors
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2021) -
Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2021) -
Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health
por: Ertl, Hildegund C. J., et al.
Publicado: (2022) -
Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma
por: Kurupati, Raj K., et al.
Publicado: (2018) -
Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19?
por: Ertl, Hildegund C. J., et al.
Publicado: (2022)